Skip to main content
Premium Trial:

Request an Annual Quote

Caliper's Q3 Revenues Rise 24 Percent

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its third-quarter revenues increased 24 percent year over year, or 16 percent organically, with strong growth for its LabChip, imaging, and research products.

The Hopkinton, Mass.-based firm brought in total revenues of $36.9 million for the three-month period ended Sept. 30, compared to $29.7 million for the third quarter of 2010. It beat the Wall Street consensus estimate of $35.6 million.

Sales for its LabChip products increased 48 percent year over year to $11.5 million from $7.8 million, while revenues for its automation products increased 32 percent to $6.9 million from $5.2 million. Sales for its research products jumped 42 percent to $18.4 million from $13 million, and revenues from imaging products were up 12 percent to $16.2 million from $14.5 million.

Caliper posted a net loss of $782,000, or $.01 per share, compared to $1.3 million, or $.03 per share, for Q3 2010. On a non-GAAP basis, it posted earnings of $1.9 million, or $.03 per share, versus $637,000, or $.01 per share, for Q3 2010. Analysts had expected a loss per share of $.01.

Caliper's R&D spending rose 27 percent to $5.6 million from $4.4 million, and its SG&A expenses climbed 19 percent to $13.1 million from $11 million.

It finished the quarter with $47.3 million in cash, cash equivalents, and marketable securities.

Caliper is in the process of being acquired by PerkinElmer for roughly $600 million. The deal had already cleared regulatory hurdles and is expected to be completed on Nov. 7, Caliper said today.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.